Studying local treatment for a few cancer spots
Part of Cancer clinical trials.
This study is for people with solid tumors that have spread to a few spots (5 or fewer) in the body. It tests whether using a focused treatment like radiation or ablation on those spots can help control the cancer long-term.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a solid tumor cancer (not a blood cancer) that has spread to other parts of the body (Stage IV).
- You should be in relatively good health, able to care for yourself (ECOG score 0-2), and your doctor expects you to live more than 6 months.
- You must have a recent scan (PET-CT, CT, or MRI) within 6 weeks of joining the study.
- You must have 5 or fewer spots of cancer that can be treated with a focused, high-dose therapy like radiation or ablation. (If more than 5, they must be close together.)
- The main tumor must be under control, or you must be planning to treat it with the same local therapy.
- You cannot be pregnant, and you must not have cancer that has spread in a way that can’t be treated locally (like in the fluid around the lungs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether high-precision radiation (SBRT) can improve outcomes for people with up to 5 small, stable metastases from certain cancers, compared to usual palliative care. It is for those whose disease is not growing after current chemotherapy.
This observational study follows people with rare solid tumors and a limited number of metastases treated with a focused radiation technique (SBRT). Doctors want to see outcomes after using a strong, curative-intent radiation dose to all active spots.
This trial tests whether giving immune-supporting cells (lymphocytes) alongside focused radiation (SBRT) can help control limited cancer spread. People with 1 to 5 small tumors that can all be radiated within two weeks may be eligible.
This trial compares two types of radiation for people whose cancer has spread to a few new spots while on or after treatment. It tests whether a precise, high-dose radiation approach (stereotactic) works better than the usual palliative radiation for controlling these growing spots.
This trial tests a faster way to give radiation to people with a few spots of cancer that have spread. They use a special scan to plan treatment right away, so you may not need a separate planning visit.
This trial tests whether giving one strong dose of radiation is as good as several smaller doses for people with a small number of cancer spots that have spread. The goal is to find a treatment that is just as effective but more convenient and with fewer side effects.
Hear when a new Oligometastatic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.